Suppr超能文献

N47K-RLC突变小鼠的心脏收缩力、运动功能及横桥动力学

Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.

作者信息

Wang Li, Kazmierczak Katarzyna, Yuan Chen-Ching, Yadav Sunil, Kawai Masataka, Szczesna-Cordary Danuta

机构信息

Departments of Anatomy and Cell Biology and Internal Medicine, University of Iowa, IA, USA.

Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, FL, USA.

出版信息

FEBS J. 2017 Jun;284(12):1897-1913. doi: 10.1111/febs.14096. Epub 2017 May 25.

Abstract

We have investigated the physiology and mechanical profiles of skinned papillary muscle fibers from transgenic mice expressing the N47K mutation in the myosin regulatory light chain (RLC), shown to cause hypertrophic cardiomyopathy in humans. The results were compared with wild-type (WT) mice, both expressing the human ventricular RLC. Rate constants of a cross-bridge (XB) cycle were deduced from tension transients induced by sinusoidal length changes during maximal Ca activation, and were studied as a function of MgATP, MgADP, and Pi concentrations. N47K mutant showed slower XB cycles but higher actin-activated ATPase activity compared with WT. Consequently, N47K exhibited larger tension than WT. K (ADP association constant) and K (equilibrium constant of force generation) were larger in N47K, and K (ATP association constant) was slightly larger in N47K vs. WT, demonstrating stronger nucleotide binding and force generation abilities of the mutant, but no changes in rigor acto-myosin binding were observed. Tension per XB was similar among groups, but N47K exhibited more XB distribution in the attached state. Larger values of tension and higher ATPase in N47K suggested that more cross-bridges participated in tension production in the mutant myocardium compared with WT. In vivo analysis of heart function, performed in ~ 12.5-month-old mice by echocardiography and invasive hemodynamics, demonstrated a significant decrease in dP/dt -end-diastolic volume relationship, indicating a depression of ventricular contractility in N47K mice. Our findings suggest that the N47K mutation exerts its action through direct alterations of myosin motor function that ultimately result in pathological hypertrophic remodeling in N47K hearts.

摘要

我们研究了在肌球蛋白调节轻链(RLC)中表达N47K突变的转基因小鼠的皮肤乳头肌纤维的生理学和力学特征,该突变在人类中可导致肥厚性心肌病。将结果与同样表达人类心室RLC的野生型(WT)小鼠进行比较。通过在最大钙激活期间由正弦长度变化诱导的张力瞬变推导横桥(XB)循环的速率常数,并研究其作为MgATP、MgADP和Pi浓度的函数。与WT相比,N47K突变体显示出较慢的XB循环,但肌动蛋白激活的ATP酶活性较高。因此,N47K表现出比WT更大的张力。N47K中的K(ADP结合常数)和K(力产生平衡常数)更大,而N47K中的K(ATP结合常数)与WT相比略大,表明突变体具有更强的核苷酸结合和力产生能力,但未观察到强直肌动球蛋白结合的变化。各组之间每个XB的张力相似,但N47K在附着状态下表现出更多的XB分布。N47K中较大的张力值和较高的ATP酶表明,与WT相比,突变体心肌中有更多的横桥参与张力产生。通过超声心动图和侵入性血流动力学对约12.5月龄小鼠进行的心脏功能体内分析表明,舒张末期容积与dP/dt的关系显著降低,表明N47K小鼠的心室收缩力降低。我们的研究结果表明,N47K突变通过直接改变肌球蛋白运动功能发挥作用,最终导致N47K心脏发生病理性肥厚重塑。

相似文献

1
Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
FEBS J. 2017 Jun;284(12):1897-1913. doi: 10.1111/febs.14096. Epub 2017 May 25.
2
Mavacamten decreases maximal force and Ca sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy.
Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H881-H890. doi: 10.1152/ajpheart.00345.2020. Epub 2020 Dec 18.
6
Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
J Mol Cell Cardiol. 2014 Sep;74:318-29. doi: 10.1016/j.yjmcc.2014.06.011. Epub 2014 Jun 30.
8
Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
J Mol Biol. 2006 Aug 11;361(2):286-99. doi: 10.1016/j.jmb.2006.06.018. Epub 2006 Jun 27.
9
Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
FASEB J. 2007 Dec;21(14):3974-85. doi: 10.1096/fj.07-8630com. Epub 2007 Jul 2.
10
Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
Cardiovasc Res. 2009 Apr 1;82(1):84-92. doi: 10.1093/cvr/cvp016. Epub 2009 Jan 15.

引用本文的文献

本文引用的文献

2
Why Is there a Limit to the Changes in Myofilament Ca-Sensitivity Associated with Myopathy Causing Mutations?
Front Physiol. 2016 Sep 26;7:415. doi: 10.3389/fphys.2016.00415. eCollection 2016.
3
Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4138-46. doi: 10.1073/pnas.1505819112. Epub 2015 Jun 29.
4
Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load.
Arch Biochem Biophys. 2015 Aug 15;580:14-21. doi: 10.1016/j.abb.2015.06.014. Epub 2015 Jun 25.
5
High ionic strength depresses muscle contractility by decreasing both force per cross-bridge and the number of strongly attached cross-bridges.
J Muscle Res Cell Motil. 2015 Jun;36(3):227-41. doi: 10.1007/s10974-015-9412-6. Epub 2015 Apr 3.
8
A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.
J Muscle Res Cell Motil. 2013 Aug;34(3-4):295-310. doi: 10.1007/s10974-013-9343-z. Epub 2013 May 23.
10
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
J Am Coll Cardiol. 2012 Aug 21;60(8):705-15. doi: 10.1016/j.jacc.2012.02.068. Epub 2012 Jul 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验